A practical approach to ABO-incompatible heart transplantation from the Pediatric Heart Transplant Society (PHTS). [PDF]
Bansal N +10 more
europepmc +1 more source
Efficacy and Safety of Plasmapheresis in Children With Acute Transverse or Flaccid Myelitis, and Guillain-Barré Syndrome. [PDF]
Fleurance A +18 more
europepmc +1 more source
Triple islet autoantibody-positive type 1 diabetes in Japanese stiff-person syndrome despite a protective HLA haplotype. [PDF]
Suenaga M +5 more
europepmc +1 more source
Timing, Composition, and Clinical Correlates of Immunotherapy Response in GAD65 Antibody-Associated Epilepsy: A Literature-Derived Patient-Level Analysis of 375 Published Cases. [PDF]
Janszky J, Janszky J, Horváth R.
europepmc +1 more source
Generalized Myasthenia Gravis with Anti-acetylcholine Receptor Antibodies during the Clinical Course of Spinal and Bulbar Muscular Atrophy. [PDF]
Kawasaki T +4 more
europepmc +1 more source
The principle of extracorporal immunoadsorption (IA) is based on affinity adsorption of pathogenic (auto-)antibodies and circulating immune complexes (CIC) which reversibly bind to an immobilized ligand of the adsorber. In pemphigus, a blistering autoimmune disease affecting skin and mucous membranes, autoantibodies, mainly of the IgG subclass are ...
Michael Hertl, Rüdiger Eming
exaly +3 more sources
Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications
Immunoadsorption is well known to selectively remove immunoglobulins and immune complexes from plasma and is applied in a variety of autoimmune diseases and for desensitization before, or at acute rejection after organ transplantation.
Adelheid Gauly +2 more
exaly +2 more sources
Related searches:
Immunoadsorption in Dermatology
Therapeutic Apheresis and Dialysis, 2012AbstractImmunoadsorption (IA) has been successfully used in a large variety of autoantibody‐mediated disorders. In dermatology, IA is increasingly applied as adjuvant treatment for severe and/or refractory autoimmune bullous diseases. These disorders are characterized by autoantibodies against structural proteins of the skin and/or mucous membranes and
Damian Meyersburg +2 more
exaly +4 more sources

